EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Effects of continuation versus interruption of oral anticoagulation during transcatheter aortic valve implantation on hemostasis function

Dirk Jan van Ginkel, Hendrik Stragier, Willem L Bor, Liesbeth Rosseel, Joke Konings, Marisa Ninivaggi, Ilaria de Simone, Dana Huskens, Mark Roest, Iris van Lenthe, Daniel C Overduin, Errol W Aarnink und 11 weitere

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.11.005 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Dirk Jan van Ginkel und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: d.van.ginkel@antoniusziekenhuis.nl. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Anticoagulants, Hemostasis, Blood Coagulation. Die Arbeit nennt 58 Literaturangaben. Gefördert von: St Antonius Hospital, Netherlands Organisation for Health Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: One-third of patients undergoing transcatheter aortic valve implantation (TAVI) have a concomitant indication for oral anticoagulation (OAC). Previous studies suggested that periprocedural continuation of OAC could reduce transient hypercoagulation after TAVI. OBJECTIVE: To evaluate the effects of continuation versus interruption of OAC on periprocedural hemostasis function. METHODS: Patients were randomized 1:1 to OAC continuation vs interruption. Plasma samples were taken at 6 time points, and hemostasis function was assessed by measuring thrombin and plasmin generation, as well as biomarkers of coagulation, fibrinolysis, platelet activation, and endothelial function. RESULTS: A total of 167 patients were included: 82 were assigned to OAC continuation and 85 to OAC interruption. Pre-TAVI, a significantly lower endogenous thrombin potential (ETP) was observed in the continuation group compared with the interruption group. In both groups, ETP was reduced immediately post-TAVI, and its restoration was significantly lower in the continuation group. In contrast, levels of prothrombin fragment 1 + 2 were similar between the groups. A significantly lower endogenous plasmin potential was observed in the continuation group from pre-TAVI to 8 hours post-TAVI. In both groups, fibrin degradation products increased immediately post-TAVI, while this increase was significantly lower in the continuation group. Markers of endothelial and platelet activation were unaffected by the randomized strategy. CONCLUSION: Continuation of OAC during TAVI modestly reduced the acute activation of coagulation and fibrinolysis compared with the interruption of OAC. This did not translate into any apparent differences in thromboembolic risk in the main trial. However, continuation of OAC resulted in a marked suppression of ETP and an increased risk of bleeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAnticoagulantsHemostasisBlood CoagulationAortic Valve StenosisHumansMaleFemaleAged, 80 and overAdministration, OralAgedTime FactorsTreatment OutcomeFibrinolysisBiomarkersDrug Administration SchedulePlatelet ActivationThrombinFibrinolysinRisk Factors

Stichwörter der Autor:innen

anticoagulantshemostasisstrokethromboembolismtranscatheter aortic valve replacement

Substanzen

AnticoagulantsBiomarkersThrombinFibrinolysin

Autor:innen und Institutionen

  • Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: d.van.ginkel@antoniusziekenhuis.nl.
  • Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands; Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Therapy, Hospital Oost-Limburg, Genk, Belgium.
  • Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Department of Cardiology, Hartcentrum Aalst, Aalst, Belgium.
  • Department of Functional Coagulation, Synapse Research Institute, Maastricht, The Netherlands.
  • Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.

Förderung

  • St Antonius Hospital
  • Netherlands Organisation for Health Research and Development

Zitieren

APA

van Ginkel, D. J., Stragier, H., Bor, W. L., Rosseel, L., Konings, J., Ninivaggi, M., de Simone, I., Huskens, D., Roest, M., van Lenthe, I., Overduin, D. C., Aarnink, E. W., Rooijakkers, M. J. P., Peper, J., Brouwer, J., Nijenhuis, V. J., Rensing, B. J. W. M., Timmers, L., Swaans, M. J., …, & Ten Berg, J. M. (2025). Effects of continuation versus interruption of oral anticoagulation during transcatheter aortic valve implantation on hemostasis function. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.11.005

Vancouver

van Ginkel DJ, Stragier H, Bor WL, Rosseel L, Konings J, Ninivaggi M, et al. Effects of continuation versus interruption of oral anticoagulation during transcatheter aortic valve implantation on hemostasis function. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.11.005

BibTeX
@article{vanGinkel2025,
  author = {van Ginkel, Dirk Jan and Stragier, Hendrik and Bor, Willem L and Rosseel, Liesbeth and Konings, Joke and Ninivaggi, Marisa and de Simone, Ilaria and Huskens, Dana and Roest, Mark and van Lenthe, Iris and Overduin, Daniel C and Aarnink, Errol W and Rooijakkers, Maxim J P and Peper, Joyce and Brouwer, Jorn and Nijenhuis, Vincent J and Rensing, Benno J W M and Timmers, Leo and Swaans, Martin J and Hackeng, Chris M and Ten Cate, Hugo and de Laat, Bas and Ten Berg, Jurriën M},
  title = {Effects of continuation versus interruption of oral anticoagulation during transcatheter aortic valve implantation on hemostasis function},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.11.005}
}
Kostenlos starten →